课题基金 / 基金详情

Improving Outcomes in Atrial Fibrillation Through Patient-Centered Decision Making

Improving Outcomes in Atrial Fibrillation Through Patient-Centered Decision Making
通过以患者为中心的决策改善心房颤动的治疗结果
批准号:
9923756
负责人:
Kathryn Anne Martinez
金额:
$13.91万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-01 至 2023-04-30

项目摘要

项目成果

Kathryn Anne Martinez的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 博士马丁内斯是医学研究所基于价值的护理研究中心的初级教员, 俄亥俄州克利夫兰市克利夫兰诊所内科助理医师。的目标 这个职业发展奖是提供行政数据分析,风险建模, 定性研究方法,以检查心房颤动患者中循证抗凝治疗的变化 房颤,并确定通过以患者为中心的决策改善房颤结局的策略 制作。心房颤动是最常见的心律失常, 增加中风的风险。抗凝治疗可以降低中风风险高达60%,但这些药物 被广泛地利用。抗凝剂有出血的风险,必须与 减少中风的预期益处。然而,医生和患者重视与以下因素相关的权衡: 抗凝剂不同。患者优先考虑避免致残性中风,而医生则担心导致中风。 流血医生经常高估个别患者的出血风险,从而无法开处方 抗凝治疗对患者可能有益。风险预测工具可以帮助医生进行循证医学 抗凝决定,但这些工具的使用是不一致的。患者对权衡的偏好 与抗凝相关的情况各不相同,但很少进行评估。考虑到患者对中风的更高评价 减少,改善以患者为中心的决策可能会增加抗凝治疗的摄取, 患者可能受益。在这个职业发展奖,马丁内斯博士提出了四个阶段的调查, 在此过程中,她将获得新的技能和能力,这些技能和能力对她实现成为一名专家的目标至关重要。 以患者为中心的抗凝决策。在目标1中,马丁内斯博士将使用决策分析模型, 在大型综合卫生系统中检查最佳抗凝处方与实际抗凝处方。在目标2中,她 将评价患者和医生关于抗凝治疗决策的沟通性质, 特别强调医生如何介绍抗凝治疗的风险和益处。因为一个关键的障碍 最佳处方是医生高估出血风险,目标3将是一项试点研究,以评估 药师主导的决策干预对改善循证和以患者为中心的影响 抗凝决策。最后,在目标4中,马丁内斯博士将召集患者焦点小组, 医生访谈,以确定改善以患者为中心的决策的具体机会, 抗凝除了通过正式课程进行高级培训外,该职业发展奖还 由一个杰出的指导团队提供支持,包括国家认可的风险建模专家, 以患者为中心的结果研究。本报告中概述的正规培训和指导研究的结合 应用程序是专门设计的,以确保马丁内斯博士从这个奖项出现作为一个独立的 研究者和以患者为中心的房颤决策专家。
英文摘要
Project Summary Dr. Martinez is a junior faculty member at the Medicine Institute Center for Value-Based Care Research and Associate Staff in the Department of Internal Medicine at the Cleveland Clinic in Cleveland, OH. The goal of this career development award is to provide training in administrative data analysis, risk modeling, and qualitative research methods to examine variation in evidence-based anticoagulation among patients with atrial fibrillation, and to identify strategies to improve outcomes in atrial fibrillation through patient-centered decision making. Atrial fibrillation is the most common cardiac rhythm disorder and is associated with a five-fold increased risk of stroke. Treatment with anticoagulation can reduce stroke risk by up to 60%, yet these drugs are widely underutilized. Anticoagulation poses a risk of bleeding, which must be weighed against the predicted benefit of stroke reduction. However, physicians and patients value the tradeoffs associated with anticoagulation differently. Patients prioritize avoiding disabling strokes, while physicians are wary of causing bleeds. Physicians often overestimate individual patients’ bleeding risk, thereby failing to prescribe anticoagulation to patients likely to benefit. Risk prediction tools can help physicians make evidence-based anticoagulation decisions, but use of these tools is inconsistent. Patient preferences for the tradeoffs associated with anticoagulation vary, but are rarely assessed. Given patients’ higher valuation of stroke reduction, improved patient-centered decision making may increase the uptake of anticoagulation among patients likely to benefit. In this career development award, Dr. Martinez proposes four phases of investigation, and in so doing will acquire new skills and competencies critical to achieving her goal of becoming an expert in patient-centered decision making for anticoagulation. In Aim 1, Dr. Martinez will use a decision analytic model to examine optimal versus actual anticoagulation prescribing in a large integrated health system. In Aim 2, she will evaluate the nature of patient and physician communication regarding anticoagulation decisions, with a particular emphasis on how physicians present anticoagulation risks and benefits. Because a key barrier to optimal prescribing is physician over-valuation of bleeding risk, Aim 3 will be a pilot study to evaluate the impact of a pharmacist-led decision intervention on improving evidence-based and patient-centered anticoagulation decision making. Finally, in Aim 4, Dr. Martinez will convene patient focus groups and conduct physician interviews to identify specific opportunities to improve patient-centered decision making for anticoagulation. In addition to advanced training through formal coursework, this career development award is supported by an exceptional mentoring team, including nationally-recognized experts in risk modeling and patient-centered outcomes research. The combination of formal training and mentored research outlined in this application is specifically designed to ensure Dr. Martinez emerges from this award as an independent investigator and an expert in patient-centered decision making in atrial fibrillation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving Adherence with Statins Through Use of the Statin Choice Decision Aid
  • 批准号:
    10683788
  • 项目类别:
  • 资助金额:
    $53.54万
  • 财政年份:
    2022
  • 负责人:
    Kathryn Anne Martinez
  • 依托单位:
Improving Outcomes in Atrial Fibrillation Through Patient-Centered Decision Making
  • 批准号:
    10402796
  • 项目类别:
  • 资助金额:
    $13.92万
  • 财政年份:
    2018
  • 负责人:
    Kathryn Anne Martinez
  • 依托单位:
海外基金